Modelling the population-level benefits and cost-effectiveness of cell-based quadrivalent influenza vaccine for children and adolescents aged 6 months to 17 years in the US

References

• World Health Organization. Influenza (Seasonal) fact sheet 2018 [cited 2022 Feb 8]. Available from: https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal)
   Google Scholar
• Uyeki TM. High-risk groups for influenza complications. JAMA. 2020;324(22):2334–2334. doi: 10.1001/jama.2020.21869
   PubMed Web of Science ®Google Scholar
• Frankl S, Coffin SE, Harrison JB. et al. Influenza-associated neurologic complications in hospitalized children. J Pediatr. 2021 Dec;239:24–31.e1.
   PubMed Web of Science ®Google Scholar
• Donnelley E, Teutsch S, Zurynski Y, et al. Severe Influenza-Associated Neurological Disease in Australian Children: Seasonal Population-Based Surveillance 2008-2018. J Pediatric Infect Dis Soc. 2022 Dec 28;11(12):533–540. doi: 10.1093/jpids/piac069
   PubMed Web of Science ®Google Scholar
• Giacchetta I, Primieri C, Cavalieri R, et al. The burden of seasonal influenza in Italy: a systematic review of influenza-related complications, hospitalizations, and mortality. Influenza Other Respir Viruses. 2022 Mar;16(2):351–365.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Disease burden of flu. 2022 [cited 2023 Jun 5]. Available from: https://www.cdc.gov/flu/about/burden/index.html
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Fluview interactive: influenza-associated pediatric mortality. 2023 [cited 2023 May 26]. Available from: https://gis.cdc.gov/GRASP/Fluview/PedFluDeath.html
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Pediatric flu deaths top 100 this season; most unvaccinated 2023. [cited 2023 Jun 5]. Available from:https://www.cdc.gov/flu/spotlights/2022-2023/pediatric-flu-deaths.htm
   Google Scholar
• Grohskopf LA, Blanton LH, Ferdinands JM, et al. Prevention and Control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices - United States, 2022-23 influenza season. MMWR Recomm Rep. 2022 Aug 26;71(1):1–28. doi: 10.15585/mmwr.rr7101a1
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). Weekly Flu Vaccination Dashboard. 2022 [cited 2022 Jun 16]. Available from: https://www.cdc.gov/flu/fluvaxview/dashboard/vaccination-dashboard.html?web=1&wdLOR=c41F416BE-120D-4E15-B54C-BD9D3E1505D6
   Google Scholar
• Olson SM, Newhams MM, Halasa NB, et al. Vaccine effectiveness against life-threatening influenza illness in US children clinical infectious diseases. Clin Infect Dis. 2022;75(2):230–238. doi: 10.1093/cid/ciab931
   PubMed Web of Science ®Google Scholar
• Worby CJ, Chaves SS, Wallinga J, et al. On the relative role of different age groups in influenza epidemics. Epidemics. 2015 Dec 01;13:10–16. doi: 10.1016/j.epidem.2015.04.003
   PubMed Web of Science ®Google Scholar
• Belongia EA, Simpson MD, King JP, et al. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. Lancet Infect Dis. 2016 Aug;16(8):942–951. doi: 10.1016/S1473-3099(16)00129-8
   PubMed Web of Science ®Google Scholar
• Ohmit SE, Thompson MG, Petrie JG, et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis. 2014 Feb;58(3):319–27.
   PubMed Web of Science ®Google Scholar
• Wu NC, Zost SJ, Thompson AJ, et al. A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine. PLOS Pathog. 2017 Oct;13(10):e1006682.
   PubMed Web of Science ®Google Scholar
• Zost SJ, Parkhouse K, Gumina ME, et al. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains. Proc Natl Acad Sci U S A. 2017 Nov 21;114(47):12578–12583. doi: 10.1073/pnas.1712377114
   PubMed Web of Science ®Google Scholar
• Imran M, Ortiz JR, McLean HQ, et al. Relative effectiveness of cell-based versus egg-based quadrivalent influenza vaccines in children and adolescents in the United States during the 2019-2020 influenza season. Pediatr Infect Dis J. 2022 Sep 1;41(9):769–774. doi: 10.1097/INF.0000000000003620
   PubMed Web of Science ®Google Scholar
• Bruxvoort KJ, Luo Y, Ackerson B, et al. Comparison of vaccine effectiveness against influenza hospitalization of cell-based and egg-based influenza vaccines, 2017-2018. Vaccine. 2019 Sep 16;37(39):5807–5811. doi: 10.1016/j.vaccine.2019.08.024
   PubMed Web of Science ®Google Scholar
• Boikos C, Fischer L, O’Brien D, et al. Relative effectiveness of the cell-derived Inactivated quadrivalent influenza vaccine versus egg-derived Inactivated quadrivalent influenza vaccines in preventing influenza-related medical encounters during the 2018-2019 influenza season in the United States. Clin Infect Dis. 2021 Aug 2;73(3):e692–e698. doi: 10.1093/cid/ciaa1944
   PubMed Web of Science ®Google Scholar
• Boikos C, McGovern I, Molrine D, et al. Review of analyses Estimating relative vaccine effectiveness of cell-based quadrivalent influenza vaccine in three consecutive US influenza seasons. Vaccines (Basel). 2022 Jun 3;10(6):896. doi: 10.3390/vaccines10060896
   PubMed Web of Science ®Google Scholar
• Boikos C, Sylvester GC, Sampalis JS, et al. Relative Effectiveness of the Cell-Cultured Quadrivalent Influenza Vaccine Compared to Standard, Egg-derived Quadrivalent Influenza Vaccines in Preventing Influenza-like Illness in 2017-2018. Clin Infect Dis. 2020 Dec 17;71(10):e665–e671. doi: 10.1093/cid/ciaa371
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Summary: ‘prevention and Control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2022-23’. 2022 [cited 2023 May 26]. Available from: https://www.cdc.gov/flu/professionals/acip/summary/summary-recommendations.htm
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Seasonal influenza vaccine supply and distribution. 2023 [cited 2023 May 26]. Available from: https://www.cdc.gov/flu/prevent/vaccine-supply-distribution.htm
   Google Scholar
• Nguyen VH, Hilsky Y, Mould-Quevedo J. The Epidemiological and Economic Impact of a Cell-Based Quadrivalent Influenza Vaccine in Adults in the US: A Dynamic Modeling Approach. Vaccines (Basel). 2021 Sep 28;9(10):1095. doi: 10.3390/vaccines9101095
   PubMed Web of Science ®Google Scholar
• Nguyen VH, Mould-Quevedo JF. Estimating the impact of influenza vaccination on acute and ICU hospital bed usage in an influenza season under endemic COVID-19 in the US. Vaccines (Basel). 2022 Nov 11;10(11):1908. doi: 10.3390/vaccines10111908
   PubMed Web of Science ®Google Scholar
• Cauchemez S, Valleron AJ, Boëlle PY, et al. Estimating the impact of school closure on influenza transmission from sentinel data. Nature. 2008 Apr 10;452(7188):750–754. doi: 10.1038/nature06732
   PubMed Web of Science ®Google Scholar
• Longini IM Jr., Koopman JS, Haber M, et al. Statistical inference for infectious diseases. Risk-specific household and community transmission parameters. Am J Epidemiol. 1988 Oct;128(4):845–859.
   PubMed Web of Science ®Google Scholar
• Molinari NA, Ortega-Sanchez IR, Messonnier ML, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007 Jun 28;25(27):5086–96. doi: 10.1016/j.vaccine.2007.03.046
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Past seasons’ vaccine effectiveness estimates 2023 [cited 2023 May 26]. Available from: https://www.cdc.gov/flu/vaccines-work/past-seasons-estimates.html
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Flu vaccination coverage, United States, 2021-22 influenza season 2022 [cited 2023 19 May]. Available from: https://www.cdc.gov/flu/fluvaxview/coverage-2022estimates.htm
   Google Scholar
• Centers for Disease Control and Prevention. CDC vaccine price list (2022-2023 season). 2022 [cited 2023 Jan 4]. Available from: https://www.cdc.gov/vaccines/programs/vfc/awardees/vaccine-management/price-list/index.html
   Google Scholar
• Prem K, Cook AR, Jit M, et al. Projecting social contact matrices in 152 countries using contact surveys and demographic data. PLoS Comput Biol. 2017 Sep;13(9):e1005697.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Past Seasons Estimated Influenza Disease Burden. 2020 [cited 2022 Jun 27]. Available from: https://www.cdc.gov/flu/about/burden/past-seasons.html
   Google Scholar
• Powell MJD The BOBYQA algorithm for bound constrained optimization without derivatives. Department of Applied Mathematics and Theoretical Physics, Cambridge (UK). 2009.
   Google Scholar
• Urueña A, Micone P, Magneres MC, et al. Cost-effectiveness analysis of cell versus egg-based seasonal influenza vaccination in children and adults in Argentina. Vaccines (Basel). 2022 Sep 28;10(10):1627. doi: 10.3390/vaccines10101627
   PubMed Web of Science ®Google Scholar
• Nguyen VH, Ashraf M, Mould-Quevedo JF. Estimating the impact of influenza vaccination of low-risk 50-64-year-olds on acute and ICU hospital bed usage in an influenza season under endemic COVID-19 in the UK. Hum Vaccin Immunother. 2023 Dec 31;19(1):2187592. doi: 10.1080/21645515.2023.2187592
   PubMed Web of Science ®Google Scholar
• Neumann PJ, Kim DD. Cost-effectiveness thresholds used by study authors, 1990-2021. JAMA. 2023 Apr 18;329(15):1312–1314. doi: 10.1001/jama.2023.1792
   PubMed Web of Science ®Google Scholar
• de Lejarazu-Leonardo R O, Montomoli E, Wojcik R, et al. Estimation of Reduction in Influenza Vaccine Effectiveness Due to Egg-Adaptation Changes—Systematic Literature Review and Expert Consensus. Vaccines (Basel). 2021 Oct 29;9(11):1255. doi: 10.3390/vaccines9111255
   PubMed Web of Science ®Google Scholar
• Jester BJ, Uyeki TM, Jernigan DB. Fifty years of influenza A(H3N2) following the pandemic of 1968. Am J Public Health. 2020 May;110(5):669–676. doi: 10.2105/AJPH.2019.305557
   PubMed Web of Science ®Google Scholar
• Reichert TA, Sugaya N, Fedson DS, et al. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med. 2001 Mar 22;344(12):889–896. doi: 10.1056/NEJM200103223441204
   PubMed Web of Science ®Google Scholar
• Biggerstaff M, Cauchemez S, Reed C, et al. Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature. BMC Infect Dis. 2014 Sep 4;14(1):480. doi: 10.1186/1471-2334-14-480
   PubMedGoogle Scholar
• Cai R, Gerlier L, Eichner M, et al. Cost-effectiveness of the cell-based quadrivalent versus the standard egg-based quadrivalent influenza vaccine in Germany. J Med Econ. 2021 Jan;24(1):490–501.
   PubMed Web of Science ®Google Scholar
• Ruiz-Aragón J, Gani R, Márquez S, et al. Estimated cost-effectiveness and burden of disease associated with quadrivalent cell-based and egg-based influenza vaccines in Spain. Hum Vaccin Immunother. 2020 Sep 1;16(9):2238–2244. doi: 10.1080/21645515.2020.1712935
   PubMed Web of Science ®Google Scholar
• Nguyen VH, Roy B. Modelling the Economic Impact of Influenza Vaccine Programs with the Cell-Based Quadrivalent Influenza Vaccine and Adjuvanted Trivalent Influenza Vaccine in Canada. Vaccines (Basel). 2022 Aug 4;10(8):1257. doi: 10.3390/vaccines10081257
   PubMed Web of Science ®Google Scholar